AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18291465 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine for 3 minutes followed by povidone-iodine for 30 seconds
Number of subjects: 100
Study 17387194 — intervention group
Group type: EXPERIMENTAL
Intervention: Apical suction device
Number of subjects: 45
Study 17387194 — intervention group
Group type: COMPARATOR
Intervention: Posterior pericardial suture
Number of subjects: 45
Study 15490822 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG spatial phase analysis in isthmus-dependent AFL
Number of subjects: 33
Study 15490822 — intervention group
Group type: COMPARATOR
Intervention: ECG spatial phase analysis in nonisthmus-dependent AFL
Number of subjects: 33
Study 15490822 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG spatial phase analysis in AF
Number of subjects: 33
Study 15490822 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG spatial phase analysis in VT-MM
Number of subjects: 33
Study 15490822 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG spatial phase analysis in VF
Number of subjects: 33
Study 15490822 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG spatial phase analysis in other SVT
Number of subjects: 33
Study 11574510 — intervention group
Group type: EXPERIMENTAL
Intervention: ZPTV measurement
Number of subjects: 86
Study 11574510 — intervention group
Group type: COMPARATOR
Intervention: Classic embryo morphology score
Number of subjects: 86
Study 9121505 — intervention group
Group type: EXPERIMENTAL
Intervention: Myoblast implantation (100 million myoblasts in the anterior tibial muscle)
Number of subjects: 10
Study 9121505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (5 mg/kg/day) for 7 months
Number of subjects: 10
Study 9121505 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in the other leg)
Number of subjects: 10
Study 7939998 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with low back pain
Number of subjects: 200
Study 7939998 — intervention group
Group type: COMPARATOR
Intervention: Volunteers
Number of subjects: 200
Study 7939998 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Patients and Volunteers)
Number of subjects: 200
Study 3128054 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous indomethacin infusion (75 mg/10 h)
Number of subjects: 97
Study 3128054 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 31821065 — intervention group
Group type: EXPERIMENTAL
Intervention: BEP treatment (bleomycin‐etoposide‐cisplatin; n = 1,819)
Number of subjects: 5185
Study 31821065 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (n = 780)
Number of subjects: 5185
Study 31821065 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance (n = 3,332)
Number of subjects: 5185
Study 31326523 — intervention group
Group type: EXPERIMENTAL
Intervention: MIND foods and speed of processing training
Number of subjects: 180
Study 31326523 — intervention group
Group type: COMPARATOR
Intervention: Control (non-MIND foods and control games)
Number of subjects: 180
Study 28520618 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus modified directly administered antiretroviral therapy (intervention)
Number of subjects: 50
Study 28520618 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 50
Study 28520618 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir hair concentration <2.35 ng/mg
Number of subjects: 50
Study 28520618 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir hair concentration >2.35 ng/mg
Number of subjects: 50
Study 28520618 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with virological failure
Number of subjects: 50
Study 25600198 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injections with no antibiotic use
Number of subjects: 1185
Study 25600198 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injections with preinjection antibiotics only
Number of subjects: 1185
Study 25600198 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injections with postinjection antibiotics only
Number of subjects: 1185
Study 25600198 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal injections with preinjection and postinjection antibiotics
Number of subjects: 1185
Study 25600198 — intervention group
Group type: EXPERIMENTAL
Intervention: Affected eyes (11 eyes with endophthalmitis)
Number of subjects: 1185
Study 23916577 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow confirmation study (FCS)
Number of subjects: 66
Study 21862744 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dietary portfolio (7 clinic visits over 6 months)
Number of subjects: 351
Study 21862744 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine dietary portfolio (2 clinic visits over 6 months)
Number of subjects: 351
Study 21862744 — intervention group
Group type: COMPARATOR
Intervention: Control diet (low-saturated fat therapeutic diet)
Number of subjects: 351
Study 19764942 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with a 5-grass pollen mixture, ultra-rush titration with doses of 30, 90, 150, and 300 IR every 20 min at the start of the pollen seasons, followed by 300 IR daily until the end of the pollen seasons.
Number of subjects: 213
Study 19764942 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 213
Study 19764942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 17607561 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest physiotherapy after routine clinical assessment
Number of subjects: 180
Study 17607561 — intervention group
Group type: COMPARATOR
Intervention: Control group (decubitus care and tracheal suctioning)
Number of subjects: 180
Study 17607561 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest physiotherapy
Number of subjects: 180
Study 17607561 — intervention group
Group type: COMPARATOR
Intervention: Chest physiotherapy and Control group
Number of subjects: 180
Study 15224283 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive program (8-session multicomponent program)
Number of subjects: 0
Study 15224283 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief program (single session)
Number of subjects: 0
Study 15224283 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 0
Study 12174058 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical arnica gel (applied twice a day for 2 weeks prior to laser treatment)
Number of subjects: 19
Study 12174058 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical arnica gel (applied twice a day for 2 weeks after laser treatment)
Number of subjects: 19
Study 12174058 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (applied twice a day for 2 weeks prior to laser treatment)
Number of subjects: 19
Study 12174058 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (applied twice a day for 2 weeks after laser treatment)
Number of subjects: 19
Study 9667702 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy within 24 hours
Number of subjects: 104
Study 9667702 — intervention group
Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy 6-8 weeks later
Number of subjects: 104
Study 9667702 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy
Number of subjects: 104
Study 7658007 — intervention group
Group type: COMPARATOR
Intervention: CVC bandage changed once a week (OAW)
Number of subjects: 32
Study 7658007 — intervention group
Group type: EXPERIMENTAL
Intervention: CVC bandage changed twice a week (TAW)
Number of subjects: 32
Study 2568529 — intervention group
Group type: EXPERIMENTAL
Intervention: APACHE-II score at admission
Number of subjects: 290
Study 2568529 — intervention group
Group type: EXPERIMENTAL
Intervention: APACHE-II score after 48 hours
Number of subjects: 290
Study 2568529 — intervention group
Group type: COMPARATOR
Intervention: Ranson score after 48 hours
Number of subjects: 290
Study 2568529 — intervention group
Group type: COMPARATOR
Intervention: Imrie score after 48 hours
Number of subjects: 290
Study 141326 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) and cyclophosphamide
Number of subjects: 360
Study 141326 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 360
Study 141326 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estramustine phosphate
Number of subjects: 360
Study 141326 — intervention group
Group type: EXPERIMENTAL
Intervention: DTIC
Number of subjects: 360
Study 141326 — intervention group
Group type: EXPERIMENTAL
Intervention: Leo 1031
Number of subjects: 360
Study 141326 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 360
Study 30543311 — intervention group
Group type: EXPERIMENTAL
Intervention: Single mass drug administration of azithromycin
Number of subjects: 96
Study 30543311 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no treatment)
Number of subjects: 96
Study 28254099 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (8 sections, once a week for 30 minutes)
Number of subjects: 22
Study 28254099 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 22
Study 25945013 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb-partitioned moxibustion combined with acupuncture (HMA)
Number of subjects: 60
Study 25945013 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine (MESA)
Number of subjects: 60
Study 22162138 — intervention group
Group type: EXPERIMENTAL
Intervention: Colposcopy with normal transformation zone (TZ)
Number of subjects: 989
Study 22162138 — intervention group
Group type: EXPERIMENTAL
Intervention: Colposcopy with abnormal transformation zone (TZ)
Number of subjects: 989
Study 22162138 — intervention group
Group type: COMPARATOR
Intervention: Colposcopy (both groups)
Number of subjects: 989
Study 22162138 — intervention group
Group type: EXPERIMENTAL
Intervention: Colposcopy with normal TZ
Number of subjects: 989
Study 22162138 — intervention group
Group type: EXPERIMENTAL
Intervention: Colposcopy with abnormal TZ
Number of subjects: 989
Study 21819581 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine manual hyperinflation (MH) performed within 30 minutes after ICU admission and every 6 hours thereafter, before tracheal extubation.
Number of subjects: 100
Study 21819581 — intervention group
Group type: COMPARATOR
Intervention: Control group (MH performed only if audible sputum present or SpO2 dropped below 92%).
Number of subjects: 100
Study 21819581 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine manual hyperinflation (MH) group.
Number of subjects: 100
Study 21819581 — intervention group
Group type: COMPARATOR
Intervention: Control group.
Number of subjects: 100
Study 19594224 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea extract plus hypocaloric diet
Number of subjects: 100
Study 19594224 — intervention group
Group type: COMPARATOR
Intervention: Hypocaloric diet only
Number of subjects: 100
Study 16317317 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole (12-24 mg/day)
Number of subjects: 187
Study 16317317 — intervention group
Group type: COMPARATOR
Intervention: Risperidone (4-10 mg/day)
Number of subjects: 187
Study 15207927 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar I Disorder subjects
Number of subjects: 38
Study 15207927 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 38
Study 11132739 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (75 mg)
Number of subjects: 120
Study 11132739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 8986513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for 16 weeks
Number of subjects: 0
Study 8986513 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-treatment manual followed by up to 8 weeks of CBT (sequential group)
Number of subjects: 0
Study 8986513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 8375517 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal ultrasound and blood samples for hormone parameters between 20 and 30 days after conception
Number of subjects: 0
Study 3739879 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol, 80 mg orally
Number of subjects: 101
Study 3739879 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem, 90 mg orally
Number of subjects: 101
Study 3739879 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine, 20 mg orally
Number of subjects: 101
Study 3739879 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary arteriography during attacks
Number of subjects: 101
Study 30028245 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy milk (240 ml daily)
Number of subjects: 70
Study 30028245 — intervention group
Group type: COMPARATOR
Intervention: Control (low-calorie diet only)
Number of subjects: 70
Study 30846916 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapulothoracic mobilization + Physical Therapy
Number of subjects: 46
Study 30846916 — intervention group
Group type: COMPARATOR
Intervention: Physical Therapy
Number of subjects: 46
Study 27020488 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 100μg
Number of subjects: 106
Study 27020488 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 8mg
Number of subjects: 106
Study 24901060 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-based psychoeducational intervention
Number of subjects: 83
Study 24901060 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 83
Study 22466411 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive stretch of ankle extensors at 20°/s
Number of subjects: 10
Study 22466411 — intervention group
Group type: COMPARATOR
Intervention: Static ankle angles (99, 98, 94, and 90° of flexion)
Number of subjects: 10
Study 22466411 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower stimulus intensity (20 % Mmax) during passive stretch
Number of subjects: 10
Study 22466411 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher stimulus intensity (Hmax) during passive stretch
Number of subjects: 10
Study 20617290 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of ascorbic acid and 400 IU of alpha-tocopherol (Tx1)
Number of subjects: 90
Study 20617290 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg of ascorbic acid and 400 IU of alpha-tocopherol (Tx2)
Number of subjects: 90
Study 20617290 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Tx0)
Number of subjects: 90
Study 18595465 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotics (Normoflorin B and Normoflorin L)
Number of subjects: 48
Study 18595465 — intervention group
Group type: COMPARATOR
Intervention: Control group (no synbiotics)
Number of subjects: 48
Study 15601345 — intervention group
Group type: EXPERIMENTAL
Intervention: ELA-Max (30 min application)
Number of subjects: 60
Study 15601345 — intervention group
Group type: COMPARATOR
Intervention: EMLA (60 min application)
Number of subjects: 60
Study 11235924 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone (400 mg/day)
Number of subjects: 105
Study 11235924 — intervention group
Group type: COMPARATOR
Intervention: Sertraline (100 mg/day)
Number of subjects: 105
Study 11235924 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 105
Study 11235924 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 105
Study 11235924 — intervention group
Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 105
Study 9553535 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented bipolar hemiarthroplasty
Number of subjects: 47
Study 9553535 — intervention group
Group type: COMPARATOR
Intervention: Cemented unipolar hemiarthroplasty
Number of subjects: 47
Study 7846199 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 12
Study 7846199 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7846199 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepulse+pulse
Number of subjects: 12
Study 3058014 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil administered three times daily (t.i.d.)
Number of subjects: 15
Study 3058014 — intervention group
Group type: COMPARATOR
Intervention: Verapamil administered twice daily (b.i.d.)
Number of subjects: 15
Study 791322 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloramphenicol
Number of subjects: 12
Study 791322 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphaphenazole
Number of subjects: 12
Study 31171419 — intervention group
Group type: EXPERIMENTAL
Intervention: D- VTd group (n=543)
Number of subjects: 1085
Study 31171419 — intervention group
Group type: COMPARATOR
Intervention: VTd group (n=542)
Number of subjects: 1085
Study 28050917 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg.kg‐1, capsule)
Number of subjects: 18
Study 28050917 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 26171624 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan-coated sutures (group 1)
Number of subjects: 101
Study 26171624 — intervention group
Group type: COMPARATOR
Intervention: Sutures without triclosan (group 2)
Number of subjects: 101
Study 23235141 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Skills Training (SST)
Number of subjects: 31
Study 23235141 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 31
Study 21622669 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent
Number of subjects: 161
Study 21622669 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stent
Number of subjects: 161
Study 18283068 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded cystine test diets with generous amounts of methionine
Number of subjects: 47
Study 18283068 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyst(e)ine intake <18 mg/kg per day
Number of subjects: 47
Study 17082779 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisofylline
Number of subjects: 0
Study 17082779 — intervention group
Group type: COMPARATOR
Intervention: Standard remission-induction therapy (idarubicin plus cytarabine)
Number of subjects: 0
Study 12971706 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pack during passive knee joint stretching
Number of subjects: 71
Study 12971706 — intervention group
Group type: COMPARATOR
Intervention: Hot pack during passive knee joint stretching
Number of subjects: 71
Study 11195305 — intervention group
Group type: EXPERIMENTAL
Intervention: Go/no-go signal precue
Number of subjects: 0
Study 11195305 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary working memory task
Number of subjects: 0
Study 11195305 — intervention group
Group type: EXPERIMENTAL
Intervention: Completely non-informative precues (congruent, incongruent, unrelated)
Number of subjects: 0
Study 9181158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous phentolamine (0.5 mg/kg over 30 min)
Number of subjects: 37
Study 9181158 — intervention group
Group type: COMPARATOR
Intervention: Opioid epidural test blockade (control)
Number of subjects: 37
Study 8344801 — intervention group
Group type: EXPERIMENTAL
Intervention: Myopia treatment
Number of subjects: 238
Study 2870010 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (0.25 mg injected subcutaneously)
Number of subjects: 16
Study 2870010 — intervention group
Group type: COMPARATOR
Intervention: Metaproterenol (inhaled via metered dose inhaler)
Number of subjects: 16
Study 31389323 — intervention group
Group type: EXPERIMENTAL
Intervention: Checklist group (CG)
Number of subjects: 28
Study 31389323 — intervention group
Group type: COMPARATOR
Intervention: Non-checklist group (NCG)
Number of subjects: 28
Study 29421967 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological Inoculation (PI)
Number of subjects: 60
Study 29421967 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 60
Study 27379563 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (n = 13)
Number of subjects: 24
Study 27379563 — intervention group
Group type: COMPARATOR
Intervention: Sham (n = 11)
Number of subjects: 24
Study 24886287 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrospective continuous glucose monitoring (r-CGM)
Number of subjects: 102
Study 24886287 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 102
Study 22848898 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading regimen
Number of subjects: 40
Study 22848898 — intervention group
Group type: EXPERIMENTAL
Intervention: Early loading regimen (6 weeks)
Number of subjects: 40
Study 22848898 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional/delayed loading regimen (12 weeks)
Number of subjects: 40
Study 22848898 — intervention group
Group type: COMPARATOR
Intervention: All loading groups
Number of subjects: 40
Study 22848898 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone types 1 and 2 (grouped together)
Number of subjects: 40
Study 22848898 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone type 3
Number of subjects: 40
Study 22848898 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone type 4
Number of subjects: 40
Study 21084039 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous ustekinumab
Number of subjects: 130
Study 21084039 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 130
Study 18996246 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based passive leg cycle exercise training (36 sessions)
Number of subjects: 17
Study 18996246 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 17
Study 18996246 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based passive leg cycle exercise training
Number of subjects: 17
Study 16417078 — intervention group
Group type: EXPERIMENTAL
Intervention: PvuII polymorphism of the ER-alpha gene
Number of subjects: 93
Study 12641682 — intervention group
Group type: COMPARATOR
Intervention: EMLA + air/O2
Number of subjects: 120
Study 12641682 — intervention group
Group type: COMPARATOR
Intervention: 50% N2O/50% O2
Number of subjects: 120
Study 12641682 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA + 50% N2O/50% O2
Number of subjects: 120
Study 10489821 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated episodes of fever and antibiotic treatment in early life
Number of subjects: 15043
Study 10489821 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of fever episodes and antibiotic courses in asthmatic children
Number of subjects: 15043